Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes

European Journal of Neurology

Volumn 14, Issue 12, 2007, Pages 1383-1391

  De Beukelaar, J W ^a   Smitt, P A Sillevis ^a   Hop, W C ^a   Kraan, J ^a   Hooijkaas, H ^a   Verjans, G M G M ^a   Gratama, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hu antibodies; Immune phenotype; Paraneoplastic syndrome; Small cell lung cancer; T lymphocytes

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; HU ANTIBODY;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG SMALL CELL CANCER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 36249008444     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01986.x     Document Type: Article

References (58)

1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. The New England Journal of Medicine 2003 349: 1543 1554.
2. Szabo A, Dalmau J, Manley G, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991 67: 325 333.
3. Byrne T, Mason WP, Posner JB, et al. Spontaneous neurological improvement in anti-Hu associated encephalomyelitis. Journal of Neurology, Neurosurgery and Psychiatry 1997 62: 276 278.
4. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993 341: 21 22.
5. Sillevis Smitt PA, Manley GT, Posner JB. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 1995 45: 1873 1878.
6. Bernal F, Graus F, Pifarre A, et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathologica 2002 103: 509 515.
7. Jean WC, Dalmau J, Ho A, et al. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994 44: 140 147.
8. Plonquet A, Gherardi RK, Creange A, et al. Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome. Journal of Neuroimmunology 2002 122: 100 105.
9. Voltz R, Dalmau J, Posner JB, et al. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998 51: 1146 1150.
10. Benyahia B, Liblau R, Merle-Beral H, et al. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Annals of Neurology 1999 45: 162 167.
11. Rousseau A, Benyahia B, Dalmau J, et al. T cell response to Hu-D peptides in patients with anti-Hu syndrome. Journal of Neuro-Oncology 2005 71: 231 236.
12. Tanaka M, Maruyama Y, Sugie M, et al. Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. Journal of the Neurological Sciences 2002 201: 9 12.
13. van den Berg AP, van Son WJ, Janssen RA, et al. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. Journal of Infectious Diseases 1992 166: 1228 1235.
14. Crane IJ, Forrester JV. Th1 and Th2 lymphocytes in autoimmune disease. Critical Reviews in Immunology 2005 25: 75 102.
15. Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology, Immunotherapy 2005 54: 721 728.
16. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004 22: 531 562.
17. Blanco P, Viallard JF, Pellegrin JL, et al. Cytotoxic T lymphocytes and autoimmunity. Current Opinion in Rheumatology 2005 17: 731 734.
18. Lonchay C, van der Bruggen P, Connerotte T, et al. Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proceedings of the National Academy of Sciences of the United States of America 2004 101: 14631 14638.
19. Borthwick NJ, Lowdell M, Salmon M, et al. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. International Immunology 2000 12: 1005 1013.
20. Hamann D, Kostense S, Wolthers KC, et al. Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. International Immunology 1999 11: 1027 1033.
21. Speiser DE, Migliaccio M, Pittet MJ, et al. Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells. European Journal of Immunology 2001 31: 459 466.
22. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003 101: 2711 2720.
23. Gratama JW, Kardol M, Naipal AM, et al. The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. Clinical and Experimental Immunology 1987 69: 16 24.
24. + subset. Journal of Immunology 1995 154: 6182 6190.
25. + T cells closely correlates with CD56 surface expression. Journal of Immunology 2000 164: 1148 1152.
26. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry 2004 75: 1135 1140.
27. Sillevis Smitt P, Grefkens J, de Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Journal of Neurology 2002 249: 745 753.
28. + T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for disease control and prevention. MMWR Recommendations and Reports 2003 52: 1 13.
29. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001 45: 194 205.
30. Gratama JW, Lipovich-Oosterveer MA, Ronteltap C, et al. Natural immunity and graft-vs-host disease. Transplantation 1985 40: 256 260.
31. Moll JW, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on Paraneoplastic Neurological Disease, held October 22-23, 1994, in Rotterdam, The Netherlands. Neurology 1995 45: 1937 1941.
32. Manley GT, Smitt PS, Dalmau J, et al. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Annals of Neurology 1995 38: 102 110.
33. Gratama JW, Naipal AM, Oosterveer MA, et al. Effects of herpes virus carrier status on peripheral T lymphocyte subsets. Blood 1987 70: 516 523.
34. Jentsch-Ullrich K, Koenigsmann M, Mohren M, et al. Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults - a monocentric German study. Clinical Immunology 2005 116: 192 197.
35. Nakamura H, Kawasaki N, Hagiwara M, et al. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung Cancer 2000 28: 139 145.
36. Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mechanisms of Ageing and Development 2000 121: 187 201.
37. Caras I, Grigorescu A, Stavaru C, et al. Evidence for immune defects in breast and lung cancer patients. Cancer Immunology, Immunotherapy 2004 53: 1146 1152.
38. Hadden JW: Immunodeficiency and cancer: prospects for correction. International Immunopharmacology 2003 3: 1061 1071.
39. Pranzatelli MR, Travelstead AL, Tate ED, et al. Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus. Journal of Pediatric Hematology Oncology 2004 26: 718 723.
40. Behan WM, Behan PO, Micklem HS, et al. Abnormalities of lymphocyte subsets in polymyositis. British Medical Journal (Clinical Research ed.) 1983 287: 181 182.
41. Erkeller-Yusel F, Hulstaart F, Hannet I, et al. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 1993 2: 227 231.
42. Iannone F, Cauli A, Yanni G, et al. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis. British Journal of Rheumatology 1996 35: 839 845.
43. Viguier M, Fouere S, de la Salmoniere P, et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine 2003 82: 82 86.
44. Chailleux E, Bignon JD, Peyrat MA, et al. Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis. Thorax 1985 40: 768 773.
45. Kolopp-Sarda MN, Kohler C, De March AK, et al. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Laboratory Investigation 2000 80: 1065 1069.
46. Hafler DA, Fox DA, Manning ME, et al. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. The New England Journal of Medicine 1985 312: 1405 1411.
47. Scolozzi R, Boccafogli A, Tola MR, et al. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. Journal of the Neurological Sciences 1992 108: 93 98.
48. Benveniste O, Cherin P, Maisonobe T, et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. Journal of Immunology 2001 167: 3521 3529.
49. Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Annals of Neurology 2000 47: 9 17
50. + T cells in healthy carriers are continuously driven to replicative exhaustion. Journal of Immunology 2005 175: 8218 8225.
51. Lin MT, Tseng LH, Frangoul H, et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood 2000 95: 3832 3839.
52. Wang H, Xu J, Ji X, et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cellular Immunology 2005 235: 117 121.
53. Wirleitner B, Obermoser G, Bock G, et al. Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clinical Immunology 2003 107: 152 159.
54. Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clinical Cancer Research 2003 9: 606 612.
55. de Andres C, Esquivel A, de Villoria JG, et al. Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. Journal of Neurology, Neurosurgery, and Psychiatry 2006 77: 562 563.
56. LeFever AV, Funahashi A. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Research 1991 51: 5596 5601.
57. Nielsen LR, Kimose HH, Linnet L, et al. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells. Journal of Clinical & Laboratory Immunology 1989 29: 71 77.
58. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. Journal of Immunology 2006 176: 1582 1587.